VKTX Archived Articles
Viking Therapeutics (VKTX): A Promising Contender in the Booming Obesity Drug Market
Published on March 15, 2025
Viking Therapeutics (NASDAQ:VKTX): A Powerhouse in the Metabolic and Endocrine Disorder Drug Development Arena
Published on November 02, 2024
Viking Therapeutics, Inc. (NASDAQ:VKTX): Advancing a Promising Pipeline of Novel Therapies
Published on September 24, 2024